Company Synaptogenix, Inc. Other OTC
Equities
SNPX
US87167T1025
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Alan Tuchman
CEO | Chief Executive Officer | 77 | 01/18/01 |
Daniel Alkon
PSD | President | 81 | 07/20/07 |
Robert Weinstein
DFI | Director of Finance/CFO | 64 | 01/13/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Alan Tuchman
CEO | Chief Executive Officer | 77 | 01/18/01 |
Bruce Bernstein
BRD | Director/Board Member | 60 | 14/16/14 |
Joshua Silverman
CHM | Chairman | 53 | 04/16/04 |
Director/Board Member | 50 | 13/18/13 | |
William Singer
BRD | Director/Board Member | 82 | 23/13/23 |
Daniel Alkon
PSD | President | 81 | 07/20/07 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,085,333 | 1,058,910 ( 97.57 %) | 0 | 97.57 % |
Stock B | 0 | 6,000 | 0 | 0 |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-0.09% | 4.21TCr | |
+49.62% | 4.2TCr | |
-4.96% | 2.92TCr | |
+11.18% | 2.6TCr | |
-21.95% | 1.89TCr | |
+8.61% | 1.32TCr | |
+24.73% | 1.22TCr | |
+28.31% | 1.22TCr | |
-6.26% | 1.14TCr |